Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect (2023 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Exchange Rate Effect of -$106000.0 for Q1 2026, down 130.2% sequentially from $351000.0 in Q4 2025, and down 1414.29% YoY from $8065.2 in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Exchange Rate Effect for 4 years, with the latest figure at -$106000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 1414.29% year-over-year to -$106000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$428000.0 (down 579.37% YoY) and the FY2025 annual result came in at -$329000.0, down 928.12% from the prior year.
- Exchange Rate Effect fell to -$106000.0 in Q1 2026 per IRWD's latest filing, from $351000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $351000.0 in Q4 2025 and troughed at -$647000.0 in Q2 2025.
- A 4-year average of -$51700.0 and a median of -$26000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2025 and 2026: Exchange Rate Effect jumped 1571.43% in 2025, then slumped 1414.29% in 2026.
- Over 4 years, Exchange Rate Effect stood at -$50000.0 in 2023, then surged by 142.0% to $21000.0 in 2024, then soared by 1571.43% to $351000.0 in 2025, then slumped by 130.2% to -$106000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$106000.0, $351000.0, and -$26000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - | 77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77,000.00 |
| Jun 30, 2026 | 77,000.00 |
| Mar 31, 2026 | -106,000.00 |
| Mar 31, 2026 | -106,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Dec 31, 2025 | 351,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -647,000.00 |
| Jun 30, 2025 | -647,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -26,000.00 |
| Sep 30, 2024 | -26,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |